Cancer Profiling Market By Technology, By Cancer Type, By Biomarker Type, By Application and By Region: Industry Analysis, Market Share, Revenue Opportunity, Competitive Analysis and Forecast 2020-2027

7755.66
Present Value (M$)
2020
15900
Forecast Value (M$)
2027
10.8%
CAGR (%)

Cancer Profiling Market is poised to value over USD 15.9 billion by 2027 end at a CAGR of over 10.8% during the forecast period 2020 to 2027

Main companies

  • Illumina
  • Inc.
  • Qiagen N.V.
  • Neogenomics
  • Inc.
  • Sysmex Corporation
  • HTG Molecular Diagnostics
  • Inc.
  • Helmonics Corporation
  • Caris Life Science
  • Nanostring Technology
  • Inc.
  • Ribomed Biotechnologies
  • Inc.
  • Guardent Health
  • Inc.
  • Medicine
  • F.Hoffmann-la-Roche ltd
  • Genscript Biotech Corporation
  • Tempus Labs
  • Histogen X